≡ Menu

Alzheimer’s–Diabetes link found

Current research indicates that there may be a link between developing diabetes in middle age and developing Alzheimer's disease later in life. Elina Rönnemaa, MD, Uppsala University, Uppsala, Sweden, reports on a study of 2,269 men in Sweden who, at 50, were tested for diabetes. During an average follow up of 32 years, 4½ percent of the participants… Read More

Clinical trial listings provided by government web site

ClinicalTrials.gov provides updated information about federally and privately supported clinical research seeking human volunteers. Information provided includes the trial's purpose, who may participate, locations, and phone numbers. Always consult your physician before pursuing involvement with a clinical trial… Read More

Alzheimer’s brains found to have high levels of iron

A recent study found that Alzheimer's patients have an elevated level of magnetic iron oxides in the area of the brain that is affected by the disease. Jon Dobson, professor, Keele University, Staffordshire, UK, looked at the brain tissue from 11 Alzheimer's disease patients and 11 age-matched control subjects. For the first time it shows… Read More

Alzheimer’s discovery involves little known lipid

Researchers found a clue to how degenerative brain disease develops with help from an unlikely source--yeast. Yeast interacts with other genes in a way that has remained unchanged over evolutionary time and is similar to the way plant and animal genes interact. What researchers found was a link between a virtually unknown signaling molecule and neuron health… Read More

Chronic pain and memory connection

University of Toronto's Dr. Min Zhuo, reports in the July 18th, Journal of Neuroscience, that there appears to be a connection between chronic pain and a patient's ability to concentrate. Zhuo injected a hind-paw of a mouse to study the spinal column activity to the area of the brain known to be involved in chronic… Read More

Life expectancy of Alzheimer’s patients varies by ethnicities

A study of nearly 31,000 patients of Alzheimer's Disease Centers across the United States reveals that African Americans and Latinos live, on average, longer than those of European or Asian descendants. All of the participants  are Alzheimer's disease patients: 82% were of European, Asian, or pure American Indian, 12% were African American, and 4% were Latino. They lived… Read More

Marijuana found to help in the battle of Alzheimer’s disease symptoms

Researchers at The Scripps Research Institute found tetrahydrocannabinol (THC), marijuana's active ingredient, inhibits the formation of amyloid plaque, which is thought to be involved with the development of Alzheimer's disease. Surprisingly, marijuana's active ingredient, THC, was found to work better at inhibiting amyloid plaque than several of the drugs approved by the Federal Drug Administration… Read More

Bad faith insurance companies

Fight Bad-faith Insurance Companies (FBIC) is an excellent site on getting the low-down on your insurance company. In previous posts it has been mentioned that there are no Federal or State laws that specifically regulate insurance policies. Sure, there are rules and regulations on how insurance companies conduct business, but when it comes to how… Read More

Generic drug manufacturers say FDA’s new approval plan falls short

As the costs of health care continues to soar, consumers are looking for ways save money. As blockbuster drugs lose their patient protection, they are being manufactured by the major generic companies like: Teva Pharmaceutical, Barr Pharmaceuticals, Mylan Laboratories, Watson Pharmaceuticals, and Novartis. In an effort to increase the number of generic drugs available to… Read More

New clues on proteins that contribute to Alzheimer’s disease

Over the past few years scientists have identified genes that are suspected in the development of Alzheimer's disease. They are just beginning to piece together what Alzheimer's related proteins do in the cell, and how they contribute to the development of the disease. Lawrence Godstein, Howard Hughes Medical Institute, and colleagues at the University of… Read More

Cymbalta used to treat fibromyalgia pain

CNN Money recently ran a Dow Jones Newswire story about Eli Lilly's recent study using Cymbalta for reducing pain in fibromyalgia patients.* Eli Lilly's study claims that after one week fibromyalgia patients using Cymbalta had less pain than the control group taking a placebo. After three months, fibromyalgia patients receiving Cymbalta experienced significantly greater reduction in… Read More

Diet helps reduce risk of dementia

Cognitive health has been added to the risk associated with obesity caused disorders. Researchers have convincing evidence that dietary practices throughout adulthood are important contributors to age related cognitive decline and dementia risk. Adults with diabetes are especially sensitive to the foods they eat with respect to cognitive function. Specifically, an adult with diabetes will… Read More